Shanghai Applied Protein Technology Co., Ltd. (APTBIO), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently…
Browsing: Legend Capital
On August 2, 2022, R&G Pharmastudies Co., Ltd. (SHE: 301333), a China-leading CRO enterprise invested by Legend Capital, was successfully…
On August 5, 2022, Legend Capital portfolio company MicuRx Pharmaceuticals, a scarce enterprise in super antibiotic, was successfully listed on…
Shenzhen Ruicycle Environmental Protection Technology Co., Ltd (also known as Hengchuang Ruineng), a battery recycling company, recently accomplished the B…
Shenzhen AKA Robotics Technology Co., LTD. (hereinafter referred to as AKA Robotics), a leading intelligent special robot company, recently completed…
On July 21st, 2022, Lunit, a leading global AI-based cancer solutions provider invested by Legend Capital, was successfully listed on…
Jiangsu Huili Biotechnology Co., Ltd (Huili Bio), a next-generation synthetic biology enzyme computational design platform, recently announced the completion of…
Legend Capital’s portfolio company Talent New Energy, a new Chinese powerhouse in the solid-state battery industry, recently announced the completion…
On June 14, two of Legend Capital’s portfolio companies, Innovent Biologics, Inc. (Innovent) and PT Etana Biotechnologies Indonesia (Etana), jointly…
On June 8th 2022, Legend Capital’s portfolio company ANYCOLOR, a leading Virtual YouTuber (VTuber) management company in Japan, was listed…
On April 26, 2022, the expedition ship Xuelong 2 for China’s 38th Antarctic expedition berthed at the Shanghai base dock.…
Legend Capital’s portfolio company Xbiome Inc., an industry-leading and AI-driven microbiome therapeutics company, recently announced that it acquired the clinical-stage…
Legend Capital’s portfolio company Lunit, a Korean Medical AI company, recently announced a preliminary approval from the Korea Exchange for…
Shanghai Langsheng Biotechnology Co., Ltd., a subsidiary of Legend Capital’s co-founded company Innostellar Biotherapeutics, announced that the clinical trial application…
On 31 March 2022, Legend Capital’s portfolio company Jiangsu Recbio Technology Co., Ltd. (Recbio, HKG: 2179), a leading novel vaccines…
On 28 February 2022, Inceptio Technology, an autonomous driving truck technology and operation company, announced its completion of a US$188…
On December 14, Legend Capital portfolio company SF Intra-city (09699.HK) successfully listed on the Hong Kong Stock Exchange (HKEx). SF…
Recently, Zhuhai Sailner 3D Technology Co., Ltd. (Sailner 3D), a leading industrial-grade color 3D printing company with independent core technology…
On November 15th, Aohua Endoscope (688212.SH), which invested by Legend Capital, was successfully listed on the Science and Technology Innovation…
On November 10th, TuringQ, China’s first photonic quantum computing company, announced its completion of a pre-A round of financing of…